In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3: Chronic Heart Failure – Diagnostic Methods
Session

Congress : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 27 May 2019
  • Time : 08:30 - 18:00

23 presentations in this session

Relationship between congestion by ultrasound, body mass index and cardiac rhythm in ambulatory patients with heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : P Pellicori (Glasgow,GB)

Using cardiovascular magnetic resonance imaging to improve classification of ejection fraction

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : DI Bromage (London,GB)

Choosing an effective methods for assessing the results of percutaneous coronary interventions in post-myocardial infarction patients

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : D Maximkin (Moscow,RU)

Variability in LVEF measured by echocardiography, gated SPECT and cardiac magnetic resonance: a real world analysis

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : B Rocha (Lisbon,PT)

Limited diagnostic accuracy of the new ASE/EACVI algorithm for heart failure with preserved ejection fraction (VEEDia-study I)

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : A van de Bovenkamp (Amsterdam,NL)

Role of 123-Iodine metaiodobenzylguanitidine imaging and cardiac MRI in ICD implantation decision making in heart failure patients

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : P Severino (Rome,IT)

Electrocardiographic predictors of ventricular tachyarrhythmias in patients with ischemic vs non-ischemic heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : T Vaikhanskaya (Minsk,BY)

An analysis of right ventricular failure in isolated left ventricular noncompaction and idiopathic dilated cardiomyopathy

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : E Libhaber (Johannesburg,ZA)

Subclinical right ventricular dysfunction in gestational hypertension as compared to a normotensive pregnancy group

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : N Patrascu (Bucharest,RO)

Relation between left ventricular filling pressure and change of left ventricular wall intensity

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : MS Kim (Jeju,KR)

Coronary venous anatomy in patients with heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : R Mlynarski (Myslowice,PL)

Comparison of right ventricular free wall regional deformation in patients with pulmonary hypertension of different aetiologies

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : N Ojrzynska (Warsaw,PL)

Does metabolic syndrome influence right ventricular diastolic function in patients with preserved left ventricular systolic function?

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : A Moiseeva (Chisinau,MD)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are